Walid Mourad

发表

SGLT2 Inhibition with Empagliflozin as a Possible Therapeutic Option for Postprandial Hypoglycemia After Bariatric Surgery

M. Zanella, Giovanna B. Carpentieri, Sandra E. A. B. Gonçalves, 2022, Obesity Surgery.